S'abonner

P56: Effect of variation in site and time on the level of ethanol and methanol in postmortem blood samples - 28/06/14

Doi : 10.1016/S2352-0078(14)70117-9 
S. Kamel

R. Darwish 1, A. Mohamed 2
1 Department of forensic medicine & clinical toxicology, faculty of medicine, university of Alexandria, Egypt 
2 Ministry of justice, Alexandria, Egypt 

Résumé

Introduction

It is well recognized that postmortem (PM) drug levels in blood may be unstable as a consequence of redistribution artifact. Whereby drugs diffuse from their binding sites of high concentration in tissues and major organs, such as liver and lung, into blood. Also drugs can be expected to diffuse from gastric contents into blood. When measuring drug concentrations after death, it is important to consider the phenomenon of PM drug redistribution. PM drug concentrations may not be a true reflection of the ante mortem one and as a result, wrong conclusions could be made about the cause of death. There is few published evidence for most drugs and poisons to show the important differences in their PM concentrations in blood and tissues according to choice of sampling site, sampling time, handling of samples including containers, preservation and documentation and type of laboratory investigation carried out on PM samples.

Aim

The present work was carried out to evaluate experimentally in rabbits PM behavior of ethyl and methyl alcohol in relation to their concentration in different blood sampling sites at different time intervals. Furthermore to assess the effect of site blood sampling on the level of ethyl alcohol and methyl alcohol at time of autopsy in human cadavers and compare it with the results from rabbit experiments.

Methods

The study was conducted on ninety male rabbits as experimental animals, and the human cadavers that were positive on screening to ethanol (n=4) and methanol (n=3) during the period of the study. Rabbits were divided into three groups (30 rabbits each), two groups for each drug, which were given the LD50 of the drug. Blood samples were drawn from right and left sides of the heart and femoral vein from each group of rabbits, immediately, twelve hours and twenty-four hours after death. As regards human cadavers, blood samples (5m1) were drawn from right and left sides of the heart and femoral vein at time of autopsy. Experimental and human blood sample extracts were analyzed by gas chromatography.

Results

The study showed that ethanol was detected in the control group after 12h PM with increased concentration overtime. The highest mean value recorded was 681μg/ml in 24h PM. No significant changes could be detected in immediate PM blood ethanol concentration (BEC) from different sampling sites. Though PM BEC increased significantly over time for the three sampling sites, yet up to 24h PM, the femoral (peripheral) BEC was the closest to the immediate PM value. Concerning methanol, the study showed also that no significant changes could be detected in immediate PM blood methanol concentration (BMC) from different sampling sites. Similarly, it increased over time for different sampling sites, where within 12h, femoral (peripheral) blood was the only site that didn’t alter significantly and could be used as a reliable indicator for the immediate PM BMC concentration. The results obtained from the human cases were generally in reasonable agreement with those of rabbit experiments.

Conclusion

Experimental animal studies, when interpreted carefully, are indicative of the PM drug changes observed in human, denoting that femoral (peripheral) blood is the best site for drug sampling.

Le texte complet de cet article est disponible en PDF.

© 2014  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 26 - N° 2S

P. S53 - juin 2014 Retour au numéro
Article précédent Article précédent
  • P55: Tableau clinique d’une ingestion de colchicine illustré par un suivi toxicocinétique
  • P. Nisse, E. Bourgogne, C. Charon, F. Baud, B. Mégarbane
| Article suivant Article suivant
  • P57: Acute ivabradine intoxication management in a critical care unit: Need for constant interaction between biological and clinical wards to follow new drug intoxication cases
  • M. Soichot, E. Bourgogne, A. Checinski, F.J. Baud, O. Laprévote

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.